Do you want to read an article? Please log in or register.
Targets for Treatment and Optimal Strategies for Non-Pharmacological and Pharmacological Management of Hypertension
Hypertension
RECOMMENDED
Related content
Hypertension
Contemporary Prevalence and Treatment Patterns Among US Adults With Apparent Treatment-Resistant Hypertension
Hypertension
Earle WB, Watson NW, Juraschek SP, Cluett JL, Krawisz AK, Secemsky EA
doi: 10.1161/HYPERTENSIONAHA.125.25659
Heart, Artery and Coronary Diseases
Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective
J Am Coll Cardiol
Cook CM, Pibarot P, Tarantini G, Généreux P, Delgado V, Hayashida K, Parma R, Kaneko T, Rudolph TK, Cavalcante JL, Wood DA, Bax JJ, Pilgrim T, Saia F, Vemulapalli S, Pellikka PA, Iung B, Guibone K, Dweck MR, Eltchaninoff H, Ailawadi G, Lam SC, Poon K, Unbehaun A, Schwartz A, Joner M, Prendergast B, Mack M, Hahn RT, Windecker S, Leon MB, Lindman BR
doi: 10.1016/j.jacc.2025.10.074
RECOMMENDED
Further Publications
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-Difference trial
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
Landmesser U, Laufs U, Schatz U, Winzer EB, Nowak B, Kassner U, Gouni-Berthold I, Esteban A, Lubyayi L, Krueger A, Hentschke C, Wilke A, Winkelmann BR, Achouba A, Banach M
doi: 10.1093/eurheartj/ehaf685
Heart, Artery and Coronary Diseases
Optimal revascularization strategy in patients with acute coronary syndrome and multivessel disease: insights from a network meta-analysis
Clin Res Cardiol
Milzi A, Benenati S, Landi A, Kahles F, Porto I, Valgimigli M
doi: 10.1007/s00392-025-02693-6
Hypertension
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)
Drugs Real World Outcomes
Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH
doi: 10.1007/s40801-025-00536-4
Hypertension
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial
JAMA Cardiol
Berman AN, Hidrue MK, Ginder C, Shirkey L, Kwatra J, O'Kelly AC, Murphy SP, Searl Como JM, Daly D, Sun YP, Curry WT, Del Carmen MG, Blankstein R, Dodson JA, Morrow DA, Scirica BM, Choudhry NK, Januzzi JL Jr, Wasfy JH
doi: 10.1001/jamacardio.2025.0871
RECOMMENDED
Hypertension
Blood Pressure 15 to 90 Days After a Hypertensive Disorder of Pregnancy and Later Hypertension
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Urrutia RP, Loop MS, Johnson JD, Wang TY, Price TM, Daubert MA
doi: 10.1161/HYPERTENSIONAHA.124.24393
Hypertension
Efficacy Determinants of Hypertension Digital Therapeutics: The B-INDEX Study
Hypertension
Kario K, Tomitani N, Harada N, Morimoto T, Okazaki O, Komi R, Sekizuka H, Nomura K, Yumino D, Katsuya T, Sato T, Uemoto K, Tanigawa T, Hisaki F, Hoshide S
doi: 10.1161/HYPERTENSIONAHA.125.25028
Hypertension
Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension
Hypertension
Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J, Narkiewicz K, Sassi-Sayadi M, Wang JG, Weber M, Schlaich M
doi: 10.1161/HYPERTENSIONAHA.125.25563